AAPL 195.34 -0.22 (-0.11%)MSFT 120.03 +1.13 (+0.95%)FB 166.05 +1.09 (+0.66%)ZNGA 5.42 -0.04 (-0.64%)NVDA 183.89 +1.36 (+0.75%)WBA 63.57 -0.19 (-0.30%)GOOG 1231.1 +7.88 (+0.64%)PIH 5.45 -0.16 (-2.85%)
AAPL 195.34 -0.22 (-0.11%)MSFT 120.03 +1.13 (+0.95%)FB 166.05 +1.09 (+0.66%)ZNGA 5.42 -0.04 (-0.64%)NVDA 183.89 +1.36 (+0.75%)WBA 63.57 -0.19 (-0.30%)GOOG 1231.1 +7.88 (+0.64%)PIH 5.45 -0.16 (-2.85%)

Financial Summary GTXI Quote GTx Inc.

GTx Inc. Quote

GTx Inc. (GTXI)

1.26 -0.04 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
D+
Symbol GTXI
Price 1.26
Beta 1.54
Vol Avg 119.86 K
Mkt cap 423.33 M
Shares 17
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered 0.00
ROE -107.14% Strong Sell
ROA -61.86% Strong Sell
Operating Margin -Infinity% Strong Sell
Debt/Equity 21.05% Neutral
P/E -0.71
P/B 0.56 Buy
Company Profile

CEO

Marc S. Hanover

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ Capital Market

Description

GTx Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of small molecules for treatment of cancer, including treatments for breast and prostate cancer and other medical conditions.